Kyle Herald, PA
Medical · Bowling Green, KYNPI 1710238266
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,690 of the $64,722 with a category attached, or 78.3%. Johnson & Johnson accounts for 73.7% of it on its own, with 34 other manufacturers making up the rest. 2025 is the largest year on record at $24,270, more than ten times the $993 reported in 2021. Among medical clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 652 payments — averaging $99.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$48K
- AbbVie$11K
- Regeneron Healthcare Solutions, Inc.$1K
- E.r. Squibb & Sons, L.L.C.$684
- UCB, Inc.$576
- Sun Pharmaceutical Industries Inc.$476
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$50,69078%
- Travel & lodging$2,7414%
- Food & beverage$10,41516%
- Education$8761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 163 | $47,729 |
| AbbVie | 148 | $10,775 |
| Regeneron Healthcare Solutions, Inc. | 49 | $1,199 |
| E.r. Squibb & Sons, L.L.C. | 49 | $684 |
| UCB, Inc. | 36 | $576 |
| Sun Pharmaceutical Industries Inc. | 20 | $476 |
| Galderma Laboratories, L.p. | 27 | $434 |
| Sanofi | 10 | $313 |
| Lilly USA, LLC | 19 | $293 |
| Pfizer | 17 | $292 |
| LEO Pharma Inc. | 17 | $280 |
| Novartis | 16 | $273 |
| Amgen | 13 | $229 |
| Arcutis Biotherapeutics, Inc. | 18 | $227 |
| Mallinckrodt Hospital Products Inc. | 5 | $134 |
| Boehringer Ingelheim | 5 | $106 |
| Dermavant Sciences, Inc. | 5 | $93 |
| Incyte Corporation | 4 | $76 |
| Chiesi USA, Inc. | 2 | $68 |
| Organon | 8 | $60 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $47 |
| Mylan Institutional Inc. | 2 | $45 |
| LNHC, Inc | 2 | $37 |
| Genentech USA, Inc. | 2 | $33 |
| Avita Medical Americas, LLC | 1 | $28 |
| Cipher Pharmaceuticals US LLC | 1 | $28 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| Biofrontera Inc. | 3 | $25 |
| AstraZeneca | 1 | $25 |
| Krystal Biotech Inc | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| EPI Health, LLC | 1 | $19 |
| Botanix SB Inc | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$64,722 in reported general payments places this provider in the 95th percentile of 222 medical providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 88 | $338,813 |
| Skyrizi PenRisankizumab-Rzaa | 12 | $248,189 |
| Dupixent SyringeDupilumab | 21 | $78,359 |
| Humira PenAdalimumab | 11 | $76,538 |
| Betamethasone Dipropionate | 133 | $6,759 |
| Fluorouracil | 52 | $4,373 |
| Clindamycin Phosphate | 57 | $4,245 |
| Clobetasol Propionate | 49 | $2,473 |
| Tretinoin | 32 | $2,155 |
| Mometasone Furoate | 105 | $2,128 |
| Dapsone | 24 | $1,944 |
| Desonide | 31 | $1,799 |
| Betamethasone Valerate | 16 | $1,531 |
| Ketoconazole | 79 | $1,374 |
| Tacrolimus | 16 | $1,322 |
Paid to pharmacies, not to this prescriber.
Other medical in Bowling Green
- Mikal BaileyPaducah$84K
- Chasity HesterLexington$16K
- Alexandra HuettLouisville$13K
- Danny ThackerFrankfort$11K
- Jessica FrizzellPaducah$10K
- Terry SmithHazard$10K
- Ashley HenegarGeorgetown$10K
- Rachel CrowleyPaducah$8K
- Allison ScottLexington$8K
- Jason MullinsCatlettsburg$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.